Loading...
Market
Which investor will increase their stake in Enifer by end of 2024?
4
Resolution / Starting Odds
Voima Ventures • 20%
FoodTech VC • 20%
Taaleri Team • 20%
Valio Ltd • 20%
FinnveraFi • 20%
Investor press releases or financial news reporting on investment increases.
Story
Finnish Startup Enifer Secures €36M for Mycoprotein Factory in Finland
May 23, 2024, 09:10 AM
Finnish biotech startup Enifer has secured €36 million ($39.1 million) in funding to build a large-scale mycoprotein factory in Finland. The funding, a mix of debt and equity, will be used to construct the first factory to produce fungal protein from sidestream materials. This facility aims to address the global protein shortage by producing up to 3,000 tons of food-grade mycoprotein annually. Enifer's innovative approach involves feeding a microbe air and electricity to create protein, showcasing a sustainable alternative to traditional agriculture. The project has garnered support from various investors, including Voima Ventures, FoodTech VC, Taaleri Team, Valio Ltd, and FinnveraFi.
View original story
Similar markets
Polygon Ventures • 20%
Animoca Brands • 20%
Mechanism Capital • 20%
Big Brain VC • 20%
Shima Capital • 20%
Polygon Ventures • 20%
Animoca Brands • 20%
Mechanism Capital • 20%
Big Brain VC • 20%
Shima Capital • 20%
Cypher Capital • 20%
Polygon Ventures • 20%
Mechanism Capital • 20%
BigBrain VC • 20%
Shima Capital • 20%
Andreessen Horowitz • 20%
Sequoia Capital • 20%
Valor Equity Partners • 20%
Tribe Capital • 20%
Saudi Arabian investors • 20%
Andreessen Horowitz • 20%
Sequoia Capital • 20%
Tribe Capital • 20%
Valor Equity Partners • 20%
Fidelity • 20%
Amazon • 20%
Meta • 20%
Nvidia • 20%
Intel • 20%
AMD • 20%
No adoption • 33%
Adoption by 1-3 companies • 33%
Adoption by 4 or more companies • 34%
0-2 • 25%
3-5 • 25%
6-8 • 25%
More than 8 • 25%
XYZ Venture Capital • 20%
CRV • 20%
Upfront Ventures • 20%
8VC • 20%
Other • 20%